[ad_1]
Today, we are releasing our final response to the Pharmac
review.
“The independent Review of Pharmac
was an opportunity for us to reflect on what we do, how we
do it, and where we can make improvements for the benefit of
all New Zealanders,” says Chief Executive Sarah
Fitt.
“To everyone who has contributed to and
worked on this response, and those who challenge us to be
better, thank you. We have entered a new phase of our
response – we are now making real changes to what we do,
so that we can make the improvements identified in the
Review
“The Review’s focus was wide – covering
our functions, governance, assessment activities, work to
support priority populations, accountabilities, and our
decision-making processes. It found that our current model
does deliver significant benefits. However, those benefits
must be shared more equitably across communities –
especially Māori and Pacific communities and people living
with disabilities.”
There are 30 actions we
committed to in the interim response – these are part of
our final response. We have reflected on our priorities, our
strengths, and our weaknesses, with our new organisational
values, Ngā
Uaratanga, helping us to imagine our
future.”
“Four key themes were identified in our
interim response which evolved into the five priorities
presented in our final response. These priorities are
connected and interrelated, and only when fully woven
together will they help us achieve better health outcomes
for Aotearoa.”
The five priorities
are:
- Enhancing assessment and
decision-making - Striving for and achieving Te Tiriti
o Waitangi excellence - Doing more to achieve health
equity - Better involvement of and collaboration with
others - Better integrating our
responsibilities
We have already made
significant progress within the actions we committed to.
Several of these are highlighted in our
, a quarterly sector update – the
first of which was released today. We are also currently
developing our Statement of Intent for 2024-2027, and the
work programmes that will underpin and give full effect to
the commitments we have made in response to the Review,”
says Ms Fitt.
“An important part of our Review
response is making sure our strengths, resources, and
capabilities match what we want to achieve. Our work has
expanded over the years. We are now kaitiaki for more than
$2 billion of taxpayers’ money we use to fund about 2000
medicines, vaccines, devices and related products. We also
oversee national contracts for around 159,000 medical
devices covering over $500 million of spending by Te Whatu
Ora hospitals.”
“Thank you to the many agencies,
groups, and individuals who have shared their experiences
and knowledge as part of the Review. It has helped us better
understand how we can support the health of all New
Zealanders.”
“We are really proud of the work we
do, and the benefits we deliver to all people in New
Zealand,” says Ms Fitt. “We look forward to progressing
with our objectives, working more closely with the rest of
the health sector, and building a better Pharmac every
day.”
Read
our full Review response on the Pharmac website
here.
© Scoop Media
[ad_2]
Source link